BRIEF published on 08/19/2024 at 18:35, 1 year 3 months ago Vergnet Pacific moves to new premises in New Caledonia Renewable Energy New Caledonia Vergnet Pacific Moving Asia-Oceania
BRIEF published on 07/12/2024 at 18:35, 1 year 4 months ago VERGNET: Technical suspension of trading Financial Report Renewable Energies Trading Suspension Vergnet
BRIEF published on 06/26/2024 at 19:05, 1 year 5 months ago Vergnet SA approves the accounts for the 2023 financial year Financial Results Renewable Energies Vergnet Photovoltaic International Contracts
BRIEF published on 06/04/2024 at 19:35, 1 year 6 months ago Vergnet: Drawing of a tranche on the ATLAS Capital Markets financing Convertible Bonds Funding Renewable Energies Vergnet ATLAS Capital Markets
BRIEF published on 05/01/2024 at 07:05, 1 year 7 months ago VERGNET: Postponement of the publication of the 2023 annual accounts Financial Report Euronext Growth Annual Accounts Postponed Publication Vergnet
Published on 12/05/2025 at 02:35, 2 hours 51 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 26 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 21 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 26 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 1 hour 55 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 35 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 10 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 15 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 26 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 41 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 41 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 25 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
